- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04071886
Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study
August 27, 2019 updated by: Lingjiang Li, Central South University
The purpose of this study is to investigate the short-term effects of mindfulness-based training in individuals suffering from major depressive disorder (MDD) as assessed by clinical interviewing, self-report assessment, cognitive evaluation and eye-tracking task.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Li Lingjiang, MD Ph.D
- Phone Number: +86 13807314575
- Email: LLJ2920@csu.edu.cn
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410001
- Recruiting
- Mental Health Institute & Faculty of Psychiatry of The Second Xiangya Hospital, Central South University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Meet Diagnostic and Statistical Manual (DSM-IV) diagnosis of depression
- Consent to participate in the study and to be randomized to one of two groups
Exclusion Criteria:
- Current or past substance abuse, psychotic disorder,obsessive compulsive disorder , Post-Traumatic Stress Disorder, in the past 6 months
- History of epilepsy or head trauma
- Eye disorders
- History of electroconvulsive therapy in the past 4 weeks.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness-Based Training
Participants in the Mindfulness-Based Training arm will receive 2 weeks of Mindfulness-Based Training for at least 30 minutes every day.
|
Mindfulness-Based Training comprises of mindful walking, body scanning and raisin meditation exercise.
Participants will receive a guided session of mindfulness meditation, and will be asked to finish at least 30 minutes of Mindfulness-Based Training every day as homework as well as keep a diary describing their experiences and reflections.
An expert in mindfulness practice will offer feedback and answer any questions online.
|
Active Comparator: Relaxation Training
Participants in the Relaxation Training arm will receive 2 weeks of Relaxation Training for at least 30 minutes every day.
|
Participants will listen to a 15-minute Relaxation Training tape twice a day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change from Baseline in Eye Movement Performance During Free-View Task at 2 Weeks
Time Frame: at baseline and in 2 weeks
|
The first fixated location and latency (msec) of each trial, the total dwell time (msec) in each interest area (IA) during the whole trial to assess the attentional bias in the experiment.
|
at baseline and in 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change from Baseline in the Symptoms of Major Depression as Measured by BDI-II at 2 Weeks
Time Frame: at baseline and in 2 weeks
|
Measured by Beck Depression Inventory (BDI-II).
BDI-II is a self-report questionnaire that measures the severity of depression on a scale of 0 to 63.
Higher total scores indicate more severe depressive symptoms.
|
at baseline and in 2 weeks
|
Mean Change from Baseline in the Symptoms of Major Depression as Measured by HAM-D at 2 Weeks
Time Frame: at baseline and in 2 weeks
|
Measured by Hamilton Rating Scale for Depression (HAM-D).
HAM-D is used by clinicians to rate the severity of depression and to evaluate recovery.
HAM-D score ranges from 0 to 51, with higher scores indicating more severe depressive symptoms.
|
at baseline and in 2 weeks
|
Mean Change from Baseline in State Mindfulness at 2 Weeks
Time Frame: at baseline and in 2 weeks
|
Measured by the Five Facet Mindfulness Questionnaire (FFMQ).
FFMQ measures five mindfulness skills through these subscales: Non-Reactivity to Inner Experience, Observing/Noticing, Acting With Awareness, Describing, and Non-Judging of Experience.
The five subscale scores can be combined to yield a total score ranging from 0 to 195, measuring global mindfulness skills, with higher scores indicating higher level of global mindfulness skills.
For FFMQ subscales, scores range from 8 to 40, except for Non-Reactivity to Experience scores, which range from 7 to 35.
Higher subscale scores indicate higher level of respective mindfulness skills.
|
at baseline and in 2 weeks
|
Mean Change from Baseline in Tendency to Engage in Ruminative Responses at 2 Weeks
Time Frame: at baseline and in 2 weeks
|
Measured by the Ruminative Responses Scale of the Response Styles Questionnaire (RRS).
RRS measures the tendency to ruminate.
RRS score ranges from 22 to 88, with higher scores indicate a stronger tendency to engage in ruminative thoughts.
|
at baseline and in 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2019
Primary Completion (Anticipated)
January 1, 2020
Study Completion (Anticipated)
January 1, 2020
Study Registration Dates
First Submitted
August 23, 2019
First Submitted That Met QC Criteria
August 27, 2019
First Posted (Actual)
August 28, 2019
Study Record Updates
Last Update Posted (Actual)
August 28, 2019
Last Update Submitted That Met QC Criteria
August 27, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Second Xiangya hospital EMEN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MDD
-
Autobahn Therapeutics, Inc.Novotech (Australia) Pty LimitedCompleted
-
University of California, San FranciscoCompleted
-
AstraZenecaCompleted
-
Unity Health TorontoActive, not recruiting
-
University of California, San FranciscoCompleted
-
University of Texas at AustinWithdrawn
-
Research Foundation for Mental Hygiene, Inc.Terminated
-
H. Lundbeck A/SCompletedAnxiety Disorders | MDDEstonia, France, Italy, Korea, Republic of, Poland, Spain
-
Duke UniversityCompleted
Clinical Trials on Mindfulness-Based Training
-
Norwegian Knowledge Centre for the Health ServicesUniversity of Oslo; University of Tromso; Norwegian Medical AssociationUnknown
-
Centro Mente Aberta de MindfulnessUnknown
-
University of Massachusetts, WorcesterCompleted
-
Duke UniversityUniversity of Colorado, Denver; University of Washington; National Center for...CompletedCardiorespiratory FailureUnited States
-
Mayo ClinicCompleted
-
Emory UniversityCompletedBehavioral Resilience | Biological ResilienceUnited States
-
The University of Texas Health Science Center at...Completed
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Al... and other collaboratorsCompleted
-
University of MiamiCompleted
-
University Health Network, TorontoActive, not recruitingObesity, Morbid | Eating Disorder SymptomCanada